Artivion to Participate in Morgan Stanley 23rd Annual Global Healthcare Conference

Artivion (NYSE:AORT), a cardiac and vascular surgery company specializing in aortic disease, announced its participation in the Morgan Stanley 23rd Annual Global Healthcare Conference.

Rhea-AI Summary

Artivion (NYSE:AORT), a cardiac and vascular surgery company specializing in aortic disease, announced its participation in the Morgan Stanley 23rd Annual Global Healthcare Conference. The company will engage in a fireside chat on September 10, 2025, at 2:35 pm ET at the Sheraton New York Times Square Hotel.

Investors can access the live webcast through Artivion's website at www.artivion.com in the Investors section. The webcast recording will remain available for 90 days following the presentation.

Argus Sep 8 session

-0.11% close to close 0.6x rel. volume Open Argus

Details

News Market Reaction – AORT

On Sep 8, the first trading day after this news, AORT closed 0.11% below the previous close.

Data tracked by StockTitan Argus for the Sep 8 session.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

ATLANTA, Sept. 5, 2025 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will participate at the upcoming Morgan Stanley 23^rd Annual Global Healthcare Conference on Wednesday, September 10, 2025, at the Sheraton New York Times Square Hotel. The Company's fireside chat is scheduled to begin at 2:35 pm ET.

A live webcast can be accessed through Artivion's website, www.artivion.com, on the Investors page.  An archived copy of the webcast will be available for 90 days on the same website. 

About Artivion, Inc.
Headquartered in suburban Atlanta, Georgia, Artivion, Inc. is a medical device company focused on developing simple, elegant solutions that address cardiac and vascular surgeons' most difficult challenges in treating patients with aortic diseases. Artivion's four major groups of products include: aortic stent grafts, surgical sealants, On-X mechanical heart valves, and implantable cardiac and vascular human tissues. Artivion markets and sells products in more than 100 countries worldwide. For additional information about Artivion, visit our website, www.Artivion.com.

Contacts:

Artivion		Gilmartin Group LLC
Lance A. Berry		Brian Johnston / Laine Morgan
Executive Vice President,		Phone: 332-895-3222
Chief Operating Officer &		investors@artivion.com
Chief Financial Officer
Phone: 770-419-3355

View original content to download multimedia:https://www.prnewswire.com/news-releases/artivion-to-participate-in-morgan-stanley-23rd-annual-global-healthcare-conference-302547997.html

SOURCE Artivion, Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When is Artivion (AORT) presenting at the Morgan Stanley Healthcare Conference 2025?

Artivion will present on Wednesday, September 10, 2025 at 2:35 pm ET at the Sheraton New York Times Square Hotel.

How can investors access Artivion's Morgan Stanley conference presentation?

Investors can access the live webcast through Artivion's website (www.artivion.com) on the Investors page. An archived recording will be available for 90 days.

What type of presentation will Artivion (AORT) give at the Morgan Stanley conference?

Artivion will participate in a fireside chat format presentation at the conference.

How long will Artivion's Morgan Stanley conference webcast be available?

The webcast recording will be available for 90 days following the presentation on Artivion's website.